Kava Extract vs Traditional Kava: A Critical Safety Distinction

Kava (Piper methysticum) is a Pacific Island plant. People in Fiji, Tonga, Samoa, and Vanuatu have used the root for centuries as a ceremonial and social drink. The classic recipe is simple: grind the fresh or dried root only, mix with cold water, strain, and drink the cloudy suspension. This water-based form of kava has a long safety record in places where rates of liver disease are not raised.

That picture changed in the early 2000s. Liver injury reports linked to concentrated kava extracts sold in capsules and tinctures led to action in several countries. Germany suspended kava products in 2002 (the BfR has updated its risk assessment several times since). Health Canada issued a stop-sale advisory in 2002. Switzerland and France withdrew kava products. The U.S. Food and Drug Administration (FDA) issued a Consumer Advisory the same year, warning of severe liver injury. Most of these reports were tied to the concentrated extracts, not to traditional water-based kava.

Why the Form Matters

Water-based kava extracts the kavalactones — the calming compounds — while leaving most other plant chemistry behind. Acetone and ethanol extracts pull out more compounds, including ones that water does not. Two extra compounds get the most attention from researchers:

• Pipermethystine. Found mainly in the leaves and stems (the aerial parts), not the root. Toxic to liver cells in laboratory studies. If a manufacturer uses cheaper aerial plant material instead of root, pipermethystine ends up in the bottle.
• Flavokavain B. Present in roots but enriched by acetone/ethanol extraction. In animal studies it triggers oxidative stress in liver cells and depletes glutathione, the body's main liver-protective molecule.

The leading hypothesis: cost-cutting in supplement manufacturing (using aerial parts and harsh solvents) likely explains why concentrated kava extracts caused harm that traditional water-based kava did not.

Does Kava Actually Work for Anxiety?

The anxiety evidence is real. A 2013 randomized controlled trial (n=75, 6 weeks) by Sarris and colleagues found kava significantly reduced anxiety scores versus placebo, with no clinically meaningful rise in liver enzymes during the trial. The 2003 Cochrane review by Pittler and Ernst pooled 11 RCTs and found kava was better than placebo for anxiety with a moderate effect size. So the question is not "does kava work?" but "which form, at what dose, and at what risk?"

What Authoritative Bodies Disagree On

This is one of the safety questions where regulators do not all agree. The World Health Organization's 2007 review concluded that root-only, water-based kava poses an "acceptably low level of risk." Germany's BfR is more cautious and continues to flag uncertainty even for root-only products. The FDA's advisory remains in place. When two authoritative sources disagree, the safer move is to assume the stricter one applies to you, especially if you take other medications or drink alcohol.

How to Minimize Risk

• Use products made from root only (look for "noble kava" or "root-only" on the label). Avoid aerial parts.
• Prefer water-based or "traditional" preparations over acetone/ethanol extracts.
• Buy from suppliers with third-party testing for pipermethystine and flavokavain B.
• Do not combine kava with alcohol, acetaminophen (Tylenol), or any drug that stresses the liver.
• Avoid kava if you have any liver disease, hepatitis, heavy alcohol use, or take prescription medications cleared by the liver.
• Limit use to short periods. Get liver enzymes (ALT, AST) checked if you use kava daily for more than a few weeks.
• Stop and see a doctor immediately if you notice yellowing of skin or eyes, dark urine, severe fatigue, or pain in the upper-right abdomen.